Newswire
ภาษาไทย
English-
CISION PR Newswire - Flagship Foldable Phone to Highlight Huawei's Prod...
SHENZHEN, China, Nov. 26, 2025 /PRNewswire/ -- Huawei will host its "Unfold the Moment" flagship product launch on December 11, 2025, in Dubai, United Arab Emirates. The event will see the unveiling o... -
CISION PR Newswire - Xinhua Silk Road: China's Weihai Int'l Port Econom...
BEIJING, Nov. 26, 2025 /PRNewswire/ -- Weihai International Logistics Park, located in Weihai International Port Economic and Technological Development District of Weihai City, east China's Shandong P... -
CISION PR Newswire - YEAHKA Accelerates Overseas Business Expansion in ...
HONG KONG, Nov. 26, 2025 /PRNewswire/ -- YEAHKA LIMITED issued a voluntary announcement. It indicates that in the third quarter of 2025, the company's overseas business continues to maintain rapid gro... -
CISION PR Newswire - The Rise of Cloud Phones: How GeeLark Is Redefinin...
SINGAPORE, Nov. 25, 2025 /PRNewswire/ -- In the past decade, social media marketing has undergone one transformation after another — from desktop-driven campaigns to mobile-first content, from post sc... -
CISION PR Newswire - Celltrion announces publication of post-hoc analys...
Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-do... -
CISION PR Newswire - Vital Signs highlights how researchers are "cracki...
HONG KONG, Nov. 26, 2025 /PRNewswire/ -- In a groundbreaking new episode, CNN's long-running series Vital Signs delves into the cutting-edge science of hibernation, revealing how the secrets of... -
CISION PR Newswire - Himeji Convention & Visitors Bureau Introduces...
HIMEJI, Japan, Nov. 26, 2025 /PRNewswire/ -- The Himeji Convention & Visitors Bureau will launch an immersive art event at Himeji Castle, a World Cultural Heritage site designated by the Japanese ... -
CISION PR Newswire - Renalys Pharma Announces Positive Topline Results ...
– In a Phase 3 clinical study evaluating the efficacy and safety of sparsentan in Japanese patients with IgA nephropathy (N=35), the percent change from baseline in the 24-hour urine protein-to-creati... -
CISION PR Newswire - Korea Innovation Foundation selects 2 Innovative b...
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces... -
CISION PR Newswire - The Adecco Group introduces the agility advantage ...
Agility advantage enables human and business agility across talent and technology solutions Strengthen run: enhancing commercial and operational excellence to drive profitable growth Accelerat...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.